secwatch.observer — SEC 8-K summary
======================================

Issuer:     United Health Products, Inc. (UEEC)
CIK:        0001096938
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0001477932-25-003453
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

United Health Products uplisted to OTCQB; FDA declines IDE for CelluSTAT study
------------------------------------------------------------------------------

- Common stock upgraded from OTC Pink to OTCQB effective May 1, 2025; ticker UEEC.
- FDA declined to approve IDE for follow-on CelluSTAT clinical study, citing BIMO audit findings from initial 2019 study.
- Company responded to audit findings in Oct 2024 and Apr 2025; teleconference with FDA scheduled within 10 days.
- No assurance that FDA Premarket Approval for CelluSTAT will be granted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1096938/000147793225003453/0001477932-25-003453-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1096938/000147793225003453/ueec_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-25-003453

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer